A clinical trial to investigate DTX-401 for the treatment of glycogen storage disease type Ia
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2017
At a glance
- Drugs DTX 401 (Primary)
- Indications Glycogen storage disease type I
- Focus Adverse reactions
- 27 Jun 2017 According to a Dimension Therapeutics media release, the company anticipates IND filing early 2018 and expect initial clinical data from the trial mid-2018.
- 29 Mar 2016 New trial record
- 24 Mar 2016 According to a Dimension Therapeutics media release, an IND filing is anticipated in 2H 2016.